A Phase I Study Evaluating the Safety and Immunogenicity of a New TB Vaccine MVA85A, in Healthy Volunteers With no Evidence of Infection With Mycobacterium Tuberculosis, in Cape Town
Phase of Trial: Phase I
Latest Information Update: 05 Mar 2016
At a glance
- Drugs MVA 85A (Primary)
- Indications Tuberculosis
- Focus Adverse reactions
- 06 Aug 2008 Status changed from in progress to completed as reported by ClinicalTrials.gov.
- 11 Feb 2008 The expected completion date for this trial is now 31 May 2008.
- 27 Jun 2007 New trial record.